COVID-19: Vaccine Advice for Children
Updated 12 January 2022
Update on Vaccines for 5-11 year olds in clinical risk groups- 09/02/2022:
Letters are being sent out by NHS England to advise parents of eligible 5-11 year olds about the COVID Vaccine. Parents will be invited in the coming weeks and months by text message or a letter to book an appointment for their child to have the vaccine at a local clinic or at a hospital hub. Appointments for the vaccine are arranged by local services or vaccination hubs rather than the cardiology team who are not able to arrange vaccine appointments.
Some areas are still in the process of determining where the vaccines will be given to this age group.
Further updates will be published to this page when we receive new information from NHS England. Please continue to check the website regularly for updates about how vaccines will be delivered.1
Children aged 5-11 years:
Children aged 5 to 11 years in a clinical risk group (as defined in the Green Book), or who are a household contact of someone who is immunosuppressed, should be offered two 10 micrograms doses of the Pfizer-BioNTech COVID-19 vaccine with an interval of 8 weeks between the first and second doses.
The minimum interval between any vaccine dose and recent COVID 19 infection should be 4 weeks.
For children aged 5-11 years of age with CHD, the guidance is that those with haemodynamically significant congenital and acquired heart disease, or milder heart disease with another co-morbidity (health condition) as listed in the Green Book should be offered the vaccine. This list can be found in Table 4 on page 21 of the Green Book (Chapter 14a).
For children aged between 12-17 years:
A booster vaccination should be offered to some young people between 12-17 years old. The following groups of children and young people should be offered a booster dose of 30 micrograms Pfizer-BioNTech COVID-19 vaccine no sooner than 3 months after completion of their primary course:
- children and young people aged 16 to 17 years
- children and young people aged 12 to 15 who are in a clinical risk group or who are a household contact of someone who is immunosuppressed
- children and young people aged 12 to 15 years who are severely immunosuppressed and who have had a third primary dose
31st December 2021 Update: To read the latest BCCA advice for COVID-19 vaccination for children and young people please click here
13th December 2021 Update: To read the latest BCCA advice for COVID-19 vaccination for children and young people please click here
19th October 2021 Update: To read the latest BCCA advice for COVID 19 vaccination for children and young people please click here
14th September 2021 Update: To read the latest BCCA advice for patients on COVID 19 vaccination in 12-15 year olds with Congenital Heart Disease please click here
The Joint Committee on Vaccine and Immunisation recently recommended that 12-15 year olds in specific risk categories should receive two doses of Covid-19 vaccine. This advice can be found here
3rd September 2021 Update: JCVI advice on vaccination of children aged 12 to 15 years with underlying health conditions
Following consideration of the updated data, JCVI advises that the offer of a course of COVID-19 vaccination should be expanded to include children aged 12 to 15 years with the following:
- Haematological malignancy
- Sickle cell disease
- Type 1 diabetes
- Congenital heart disease – Haemodynamically significant congenital and acquired heart disease, or milder heart disease with other co-morbidity.
- Other health conditions as described below under ‘COVID-19 clinical risk groups for children aged 12 to 15 years’ (these health conditions reflect the basket of diagnoses used in the RCPCH and NHSE analyses mentioned above).
Please click here for more information and to read the latest JCVI vaccination update in full.